Navigation Links
Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
Date:12/12/2008

EMERYVILLE, Calif., Dec. 12 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) will present findings on the mechanism of action of its anti-cancer agent BN108 at the 31st Annual San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center, San Antonio TX, December 10-14, 2008.

Bionovo's poster presentation will describe the pathway for cancer cell apoptosis (cell death) induced by BN108. As explained by Dr. Emma Shtivelman, Director of Cancer Research at Bionovo, BN108 induces death in cancer cells but not in normal cells. BN108 induces apoptosis through induction of stress in the endoplasmic reticulum. Laboratory studies show that BN108 inhibits major oncogenic pathways, and therefore, can be used for many different cancers.

"BN108 mechanism of action and unique selective properties are a result of some of the distinct biological differences between cancer cells and normal cells. We believe BN108 will result in better selectivity to various cancers with no collateral damage to normal tissues. BN108 is designed to be an oral drug candidate that will provide a chronic treatment option with a low toxicity profile," said Dr. Isaac Cohen, Chairman and CEO of Bionovo,

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bio
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
2. John D. Baxter, M.D. Joins Bionovos Board of Directors
3. Bionovo to Present at the Cambria Capital Investor Meeting
4. Bionovo Announces 2007 Financial Results and Highlights
5. Bionovo Describes a New Class of Therapeutic Compounds
6. Bionovo Announces Closing of Public Offering of Common Stock
7. Smart Balance Presented to the Consumer Analyst Group of New York
8. Late preterm births present serious risks to newborns
9. Hoana Medical to Present at the National Forum on Quality Improvement in Health Care
10. GRF to Present Groundbreaking Research for Glaucoma at January 28 Gala
11. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Tbdress.com has recently announced that its Special Friday ... The special offer will provide ladies many gorgeous shoes at ... world’s largest women’s dresses retailers, and its shoes include many ... discounts on that day: Everything at Tbdress.com is up to ... $89). , People can use the following coupon codes as ...
(Date:11/23/2014)... 23, 2014 (HealthDay News) -- The holidays can be ... sensory overload can trigger major meltdowns, an expert says. ... best of circumstances, but when you have children with ... an occupational therapy professor at University of the Sciences ... "It,s best to let your hosts or visitors know ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power ... company has announced its new collection of power suppliers. ... high quality power suppliers. All the new models come ... offer lasts until Dec. 20, 2014. , SWAccessControl.com has ... been supporting it for a long time. It is ...
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... BambooFlooringChina.com , the world’s leader in bamboo flooring, has ... collection. Now, the business is announcing big discounts on ... is valid until Dec. 20, 2014. , The new click ... surface, which makes it very easy to maintain. As one ... to make its website the best shopping platform for people ...
Breaking Medicine News(10 mins):Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2
... (HealthDay News) -- As parents prepare to send their children ... an important factor in academic performance, an expert advises. ... and lunches are more alert throughout the school day and ... diet, says Mary Pat Alfaro, clinical manager of the division ...
... pharmacies and health food shops are still lacking important ... Leeds researchers. In April this year, a new ... traditional herbal medicines, such as St John,s wort and ... possible side effects, how they could interact with other ...
... multiple myeloma trial has unexpectedly revealed that the drug ... its dose level in the body, say researchers at ... G. James Cancer Hospital and Richard J. Solove Research ... is an anti-inflammatory drug, and more than 390 clinical ...
... , MONDAY, Aug. 8 (HealthDay News) -- One ... playing video games may be because the games allow them ... new study suggests. The research included hundreds of casual ... asked about their motivation for playing, as well as their ...
... 8 (HealthDay News) -- Frequent visual field testing may help ... earlier stage, a new study says. It,s important to ... can receive more aggressive treatment or more frequent follow-up, the ... the journal Archives of Ophthalmology , included 381 glaucoma ...
... Reinberg HealthDay Reporter , MONDAY, Aug. 8 ... in controlling tremors and improving motor function for those ... years, according to a small new study by Canadian ... called motor system disorders, which are caused by the ...
Cached Medicine News:Health News:Healthy Lunch and Breakfast Keep Students Alert 2Health News:Herbal remedies escape EU law 2Health News:Study urges caution with lenalidomide dosage 2Health News:Frequent Tests Help Track Progression of Glaucoma, Study Finds 2Health News:Deep Brain Stimulation Improves Parkinson's Symptoms Long-Term 2Health News:Deep Brain Stimulation Improves Parkinson's Symptoms Long-Term 3
(Date:11/22/2014)... DUBLIN , Nov. 21, 2014 Research ... "China Recombinant Protein Drug Industry Report, 2014-2017" report ... The Chinese recombinant protein drug market ... demand rigidity, consumption ability and the like. During 2005-2013, ... hospitals grew at a CAGR of 19.1%, and it ...
(Date:11/21/2014)... , Nov. 21, 2014  Alere Inc. (NYSE: ... diagnostic tests, has appointed Juliet Cunningham as ... Cunningham will be responsible for driving communications with the ... on a series of changes to increase shareholder value, ... to investors," said Namal Nawana, Chief Executive Officer. "We ...
(Date:11/21/2014)... and VIENNA, Va. , Nov. ... care provider that operates in Southern California ... provider of remote caregiving technology. Alta will be providing ... client receiving homecare services. Logo - ... is the key to providing the kind of affordable ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2
... Silence Therapeutics plc (AIM: SLN) ("Silence"), a ... announces that it has entered into an agreement with ... investigate the application of Silence,s proprietary DACC delivery technology ... siRNAs ") to the pulmonary vascular endothelium. ...
... September 27, 2011 NVA237 has ... European Medicines Agency (EMA) under the brand-name Seebri® Breezhaler®, ... Studies show investigational once-daily NVA237 provides superior ... Additional data show NVA237 significantly prolonged time ...
Cached Medicine Technology:Silence Therapeutics Signs siRNA Delivery Collaboration With Top 10 Pharma Company 2Silence Therapeutics Signs siRNA Delivery Collaboration With Top 10 Pharma Company 3Silence Therapeutics Signs siRNA Delivery Collaboration With Top 10 Pharma Company 4NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress 2NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress 3NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress 4
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... The definition of dexterity in ... to grip firmly and release easily, ... comfort and security. A three- or ... control during stone retrieval. These graspers ...
... grasping technology allows the ... in a shorter length ... to the stone. The ... ergonomic one-handed operation. Supplied ...
Medicine Products: